Lung Fibrosis after Chemotherapy Containing Docetaxel in a Patient Treated for Breast Cancer
Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2015, Vol 4, Issue 4
Abstract
Docetaxel has proven effective in many solid tumors, including breast cancer. Hypersensitivity reactions are the most common toxicity associated with docetaxel. However, acute interstitial pneumonia is rarely reported in the literature. We report the case of a woman born in 1969, treated for invasive ductal carcinoma of the left breast and who presented 6 years later with an invasive ductal carcinoma locally advanced in the right breast. Neo-adjuvant chemotherapy based on docetaxel was indicated. Fifteen days after the third course, she had a stage IV dyspnea with a dry cough. Chest radiography showed a bilateral diffuse interstitial infiltrate appearance labeled as an acute interstitial lung disease secondary to docetaxel. The outcome was good after a high dose of corticosteroids. Clinicians should be aware of the risk of interstitial lung disease with docetaxel and introduce a special monitoring of lung function.
Authors and Affiliations
Abdeslam HASSOUNI
Keywords
Related Articles
- EP ID EP198230
- DOI 10.19070/2167-9118- 1500012
- Views 81
- Downloads 0
Stochastic Mathematical Models of Carcinogenesis
Geneticists and molecular biologists have demonstrated that carcinogenesis is a stochastic multi-stage process with each cancer tumor being derived from a single stem cell which has sustained a finite number of genetic a...
Anticancer Activity of Acetone Extract of Quercus infectoria Olivier Fagaceae in 1,2 Dimethyl Hydrazine Induced Colon Cancer
Quercus infectoria Olivier (Fagaceae) which contains abundant amount of hydrolysable tannins and traces of gallic acid, ellagic acid and sitosterol is reported to be effective in inflammatory bowel disease. In the presen...
Frequency and Determining Factors of Empiric Chemotherapy Dose Reduction in Patients with Non-Small Cell Lung Cancer
Objectives: To determine the frequency and key factors regarding empiric chemotherapy dose reductions (ECDR) in nonsmall cell lung cancer (NSCLC) patients. Methods: This retrospective study involved the chart review of...
Intracystic Papillary Carcinoma of The Breast a Rare Tumor in Male
Intracystic papillary carcinoma of the breast in men is an extremely rare disease with an excellent prognosis. Here, we report a new case of intracystic papillary carcinoma of the breast in a 79- year-old man. He was adm...
Validation Trial of a Novel Marker of Delayed Chemotherapy-induced Emesis
Post hoc analyses of study data suggested that the ratio of substance P to 5-HIAA/creatinine was a novel marker associated with risk of developing delayed chemotherapy-induced emesis. In order to verify this finding, a n...